New JV agreement with Volz Holdings

By

Regulatory News | 10 Dec, 2021

Updated : 13:34

RNS Number : 3188V
Nanosynth Group PLC
10 December 2021
 

 

10 December 2021

 

nanosynth group plc

("nanosynth", the "Company" or the "Group")

New JV agreement with Volz Holdings to produce antiviral HVAC filtration media

nanosynth group plc, the AIM quoted company is pleased to announce that it has entered into a new Joint Venture Agreement (the "JV") with, inter alia, Volz Holding v.o.s (the "Parties") forming the basis upon which the Parties intend to develop, market and sell an anti-pathogenic product for the global filtration market. The Company will initially own 51% of the JV.

nanosynth and Volz have each agreed to licence their respective proprietary filtration and manufacturing technologies to the JV for the purpose of producing an anti-pathogen product for the global filtration market. Specifically, P2F have licenced their antipathogenic IP (PCT/GB2021/052733, NANOPARTICLES FOR USE IN ANTI PATHOGENIC APPLICATIONS) to the JV.  The JV agreement has been entered into on the basis of an agreed business plan and marketing and sales strategy. Each of the Parties will be represented on the JV board of directors.

Up to £50,000 of funding for initial working capital for the JV will be provided by the Company under the terms of a loan agreement which has also been entered into.

The Volz Group is predominately a major manufacturer of air filtration media and filter products for use in HVAC systems, with production facilities in Germany, Slovakia and the U.K. totalling more than 80,000m2.  The group has a diversified platform and specialist Tier 1 CNC engineering processing capabilities.

Further updates on the progress of the JV will be made as and when significant milestones are achieved.

 

Mark Duffin, CEO commented: "I am delighted to be able to report the signing of the JV agreement with Volz which has the potential for us to develop an outstanding HVAC product at a time of great need around the globe. With the unfortunate prospect of further COVID variants likely in the future, we envisage excellent longer term sales prospects. We very much look forward to working with Volz on this innovative project using our proprietary technology."

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018.  Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside is now considered to be in the public domain.

 

 

 

 

ENQUIRIES :

nanosynth group plc

Mark Duffin (Chief Executive Officer)  via IFC Advisory

 

SP Angel Corporate Finance LLP                                          +44 20 3470 0470

Nominated Adviser and Joint Broker

Stuart Gledhill

Caroline Rowe

 

IFC Advisory Ltd  +44 20 3934 6630

Graham Herring

Zach Cohen

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
JVEFLFFVFALILIL

Last news